TITLE

Combinatorial Synthesis and Virtual Screening of Novel Oxazine and Thiazine Mini Libraries for Antidiabetic Activity

AUTHOR(S)
More, S. A.; Bhatia, N. M.
PUB. DATE
August 2014
SOURCE
Asian Journal of Research in Chemistry;Aug2014, Vol. 7 Issue 8, p751
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The purpose of the present work was to investigate, following previous works, oxazine and thiazine analogues as antihyperglycemic agent by carrying out docking studies. A series of substituted oxazine and thiazine has been synthesized combinatorially and intermediate compounds were confirmed from the results of chromatographic, spectral and physicochemical analysis. By comparing the interactions of the reference and synthesized molecules with selected target enzymes DPP-4 and glucokinase enzyme, it is clear that the compound can bind strongly with the receptor molecules which suggest that rationale used to optimize structural requirements of ligand with respect to selected targets was appropriate. Two molecules 4-(4-aminophenyl)-6-(2-chloroquinolin-3-yl)-N-pyridin-2-yl-6H-1,3- oxazin-2-amine (A6B3) and 4-(2,4-dimethyl-1H-pyrrol-3-yl)-6-(2,4-dimethoxyphenyl)-N-(pyridin-2-yl)-6H-1,3- oxazin-2-amine-2-carboxylate (A4B3) showed good antidiabetic activity.
ACCESSION #
98425034

 

Related Articles

  • GREEN SYNTHESIS OF THIAZINE AND OXAZINE DERIVATIVES - A SHORT REVIEW. Didwagh, Sayaji S.; Piste, Pravina B. // International Journal of Pharmaceutical Sciences & Research;Jun2013, Vol. 4 Issue 6, p2045 

    A survey of green synthesis of thiazines and oxazines revealed the moiety have attracted a great deal of interest of medicinal chemist, biochemist, pharmacologist and rendered as a lead molecule for designing potential bioactive agents. This review accompanying supplementary green synthetic...

  • American Diabetes Association.  // BioWorld Today;6/29/2010, Vol. 21 Issue 124, p6 

    The article reports on the Phase II results revealed by Halozyme Therapeutics Inc. which demonstrated that the subcutaneous coinjection of recombinant human hyaluronidase, PH20 (rHuPh20) with lispro significantly improves postprandial hyperglycemia, reduced hypoglycemia and accelerates the...

  • METFORMIN.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p542 

    The article presents information on metformin, an antidiabetic drug, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • Antihyperglycemic activity of methanolic extract of Leucas clarkei Hook. sahu, Satyabrata; Swain, Trupti Rekha; Danta, Chhanda Charan // Journal of Pharmacy Research;Oct2010, Vol. 3 Issue 10, p2508 

    An antihyperglycemic activity has been studied by taking the methanolic extract of dried leaves of Lucas clarkei Hook (Lamiaceae). The extraction was done by cold maceration and successive solvent extraction process. This research work was completed in a time period of 14 days by selecting the...

  • IN-SILICO DOCKING STUDIES OF SELECTED N-GLYCOSIDE BEARING TETRAZOLE RING IN THE TREATMENT OF HYPERGLYCEMIA SHOWING INHIBITORY ACTIVITY ON SGLT. KUMARI, BABITA; CHETIA, DIPAK // International Journal of Pharmacy & Pharmaceutical Sciences;2013 Supplement 2, Vol. 5, p633 

    Objective: Sodium glucose co transporter (SGLT) inhibitor is a novel approach which is different from the available antidiabetic therapies. This class of drugs targets insulin resistance and insulin deficiency, providing a glucose dependent and insulin-independent pathway to control...

  • Antidiabetic Effects of Pterosin A, a Small-Molecular-Weight Natural Product, on Diabetic Mouse Models. Feng-Lin Hsu; Chun-Fa Huang; Ya-Wen Chen; Yuan-Peng Yen; Cheng-Tien Wu; Biing-Jiun Uang; Rong-Sen Yang; Shing-Hwa Liu // Diabetes;Feb2013, Vol. 62 Issue 2, p628 

    The therapeutic effect of pterosin A, a small-molecular-weight natural product, on diabetes was investigated. Pterosin A, administered orally for 4 weeks, effectively improved hyperglycemia and glucose intolerance in streptozotocin, high-fat diet-fed, and db/db diabetic mice. There were no...

  • EMD387008, a New Antidiabetic Compound, Inhibits Hepatic Gluconeogenesis through Gluconeogenic Gene Regulation and AMPK Activation. Raynal, Sophie; Audet, Annick; M├ęSangeau, Didier; Durbin, Philippe; Augert, Guy // Diabetes;Jun2007 Supplement 1, Vol. 56, pA157 

    EMD387008 was previously shown to decrease hyperglycemia of diabetic rats partly by a gluconeogenesis inhibition. This 1st representative of a new class is currently under clinical development for T2DM treatment. The study objective was to investigate in vitro the mechanism of EMD387008-induced...

  • ACARBOSE. Griffith, H. Winter // Complete Guide to Prescription & Nonprescription Drugs 2012;2009, p6 

    The article presents information on acarbose, and antihyperglycemic and antidiabetic drug, including dosage, usage, adverse reactions, side effects, precautions, and possible interaction with other drugs.

  • Antihyperglycaemics: prescribing rate unchanged by rosiglitazone warning.  // PharmacoEconomics & Outcomes News;12/12/2009, Issue 593, p4 

    The article discusses research on antihyperglycemic utilization. It references the study "Temporal trends in anti-diabetes drug use in tricare following safety warnings in 2007 about rosiglitazone," by K. A. Stewart and colleagues, published in the November 2009 issue of "Pharmacoepidemiology...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics